| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |